Lobbying client

WORKING GROUP FOR PHARMACEUTICAL SAFETY

Advocacy Coalition working to improve pharmaceutical safety

Filings
15
Filed by
1
Reported in-house
—
Reported by firms
$410,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2013 to 2016

Filings

15 filings, newest first.
Filing Filed by Amount
3rd Quarter - Termination (No Activity)
3rd Quarter 2016
BGR GOVERNMENT AFFAIRS — reported
2nd Quarter - Report (No Activity)
2nd Quarter 2016
BGR GOVERNMENT AFFAIRS — reported
1st Quarter - Report (No Activity)
1st Quarter 2016
BGR GOVERNMENT AFFAIRS — reported
4th Quarter - Report (No Activity)
4th Quarter 2015
BGR GOVERNMENT AFFAIRS — reported
3rd Quarter - Report (No Activity)
3rd Quarter 2015
BGR GOVERNMENT AFFAIRS — reported
2nd Quarter - Amendment
2nd Quarter 2015
BGR GOVERNMENT AFFAIRS $50,000 reported
1st Quarter - Amendment
1st Quarter 2015
BGR GOVERNMENT AFFAIRS — reported
4th Quarter - Report
4th Quarter 2014
BGR GOVERNMENT AFFAIRS $30,000 reported
3rd Quarter - Report
3rd Quarter 2014
BGR GOVERNMENT AFFAIRS $30,000 reported
2nd Quarter - Report
2nd Quarter 2014
BGR GOVERNMENT AFFAIRS $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
BGR GOVERNMENT AFFAIRS 14 $410,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 10

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.